Coronavirus:
Insights
-
1 June 2020
Finding a cure for HIV with ViiV Healthcare and UNC-Chapel Hill
ViiV Healthcare has announced that it will renew its partnership with the University of North Carolina at Chapel Hill. The partners have been collaborating on the search for an HIV...
-
28 May 2020
No time to waste: repurposing drugs to tackle Covid-19
There is an urgent need for safe and effective drugs to combat the escalating Covid-19 pandemic. Novel vaccines and drugs are not going to be a short-term solution to this...
-
27 May 2020
Generics and the Covid-19 pandemic: Q&A with Accord’s Dr Anthony Grosso
Like all industries, the pharma industry has been disrupted by the Covid-19 pandemic. The generics industry has been impacted particularly by supply chain problems and huge surges in demand for...
-
26 May 2020
Veeva R&D summit 2020: putting patients at the centre of clinical research
Despite the Covid-19 pandemic, Veeva held its European R&D summit in May where it launched the industry’s first end-to-end solution for drug development: Clinical Network. A crucial component of Clinical...
-
21 May 2020
Rapid Micro Biosystems raises $120m: improving contamination testing in pharma
Rapid Micro Biosystems has raised $120m in a funding round to support further expansion and uptake of its automated, rapid microbial detection technology for manufacturing, Growth Direct. What role has...
-
20 May 2020
Canadian Government invests $175.6m in AbCellera’s Covid-19 response
AbCellera has received $175.6m through the Canadian Government’s Strategic Innovation Fund to support the development and manufacturing of antibody drugs against Covid-19, as well as allow for better preparedness for...
-
18 May 2020
How to launch a drug in a pandemic with Immunomedics
During the ongoing Covid-19 pandemic, the FDA has continued in its normal role of approving safe and effective drugs. But how do pharma companies go about bringing a new drug...
-
11 May 2020
Covid-19 pandemic: a deep dive into the UK’s ACCORD programme
To accelerate drugs through the early stages of clinical development and into large-scale UK studies, the UK Government’s Covid-19 Therapeutics Taskforce has created the ACCORD programme, with BerGenBio’s bemcentinib the...
-
30 April 2020
Coronavirus in India: how the COVID-19 could impact the fast-growing economy
India reported the first confirmed case of the coronavirus infection on 30 January 2020 in the state of Kerala. The affected had a travel history from Wuhan, China.
-
29 April 2020
Covid-19 pandemic: how modelling can support drug development
Central to the fight against Covid-19 is the clinical development of drugs, including novel compounds and those already approved for other indications. One way to support these efforts is through...